Haemonetics gets plasma separation approval:
This article was originally published in Clinica
Executive Summary
The US FDA has approved Haemonetics' leucocyte apheresis protocol. The approval will allow users of the company's PCS2 blood processing system to separate 130-155 ml of leucocytes at the same time as producing 450-750 ml of plasma from donor blood.